Insights & Resources

The SEC’s new regulations for safeguarding crypto assets and the administration’s executive order are changing the landscape for digital assets.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

This webinar summary covers changes to the TCJA, tax rates and credits, new requirements for ASC 280 and ASC 740 and year-end impairment reminders.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

Learn how ASU 2023-09 enhances income tax disclosures with new rate reconciliation and cash flow reporting requirements for public entities.

Weaver’s overview of the SEC’s 2025 examination priorities describe practices by investment advisers and others that may come under SEC review.

Weaver professionals discuss the U.S. Supreme Court’s decision to overturn the Chevron doctrine, cybersecurity and accounting reminders on goodwill impairment.

The home health and hospice sectors are facing significant challenges with personal care emerging as the key sector for mitigating risk.

Weaver’s second quarterly Accounting and SEC Update of 2024 covered stock compensation and other standards updates, filer status assessments and recent SEC/ PCAOB enforcement actions.

When is a valuation allowance needed in a company’s financial statement? Find out more about valuing deferred tax assets in financial statements.

As more regulatory bodies adopt requirements involving environmental and sustainability metrics, businesses will need better ways to collect, manage and aggregate that data. Weaver offers five steps for getting started.

Weaver professionals discuss segment reporting, Effective Tax Rate calculation, SEC’s climate rules, megatrends impacting risk assessments and AI in the workplace.